Imprivata Company Profile (NYSE:IMPR)

About Imprivata (NYSE:IMPR)

Imprivata logoImprivata, Inc. (Imprivata) is a United States-based healthcare information technology security company. The Company enables healthcare organizations to access, communicate and transact patient information securely. The Company offers Imprivata OneSign, Imprivata Cortext, Imprivata Confirm ID and Imprivata PatientSecure. Imprivata OneSign provides single sign-on, authentication management and virtual desktop roaming, enabling No Click Access to clinical applications and patient information, anytime, anywhere and from any device. Imprivata Cortext enables clinicians to collaborate across care teams and organizations. Imprivata Confirm ID is an identity and two-factor authentication platform for remote access, electronic prescriptions for controlled substances (EPCS), medical device access and other clinical authentication workflows. Imprivata PatientSecure is a patient identification solution that uses palm vein recognition biometrics to identify patients at any point of entry to care.

Industry, Sector and Symbol: Average Prices:
  • 50 Day Moving Avg: $19.26
  • 200 Day Moving Avg: $19.25
  • 52 Week Range: $10.81 - $19.28
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -107.00
  • P/E Growth: 0.00
  • Net Margins: -17.22%
  • Return on Equity: -58.85%
  • Return on Assets: -22.17%
  • Current Ratio: 1.31%
  • Quick Ratio: 1.31%
  • Beta: -1.21

Frequently Asked Questions for Imprivata (NYSE:IMPR)

What is Imprivata's stock symbol?

Imprivata trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMPR."

How were Imprivata's earnings last quarter?

Imprivata Inc (NYSE:IMPR) issued its quarterly earnings data on Tuesday, February, 16th. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.10) by $0.01. The business had revenue of $34.20 million for the quarter, compared to analyst estimates of $33.15 million. Imprivata had a negative net margin of 17.22% and a negative return on equity of 58.85%. The firm's quarterly revenue was up 17.9% on a year-over-year basis. During the same period last year, the business posted ($0.04) earnings per share. View Imprivata's Earnings History.

Who are some of Imprivata's key competitors?

How do I buy Imprivata stock?

Shares of Imprivata can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imprivata's stock price today?

One share of Imprivata stock can currently be purchased for approximately $19.26.

MarketBeat Community Rating for Imprivata (NYSE IMPR)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  113 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Imprivata and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Imprivata (NYSE:IMPR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Imprivata (NYSE:IMPR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/2/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
7/14/2016Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
7/13/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
7/13/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
5/31/2016Oppenheimer Holdings, Inc.Reiterated RatingBuy$16.00N/AView Rating Details
5/4/2016J P Morgan Chase & CoReiterated RatingHold$17.00N/AView Rating Details
2/17/2016Barclays PLCLower Price TargetOverweight$15.00 -> $14.00N/AView Rating Details
11/3/2015Topeka Capital MarketsLower Price TargetBuy$20.00 -> $17.00N/AView Rating Details
10/15/2015William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 8/18/2015 forward)


Earnings History for Imprivata (NYSE:IMPR)
Earnings by Quarter for Imprivata (NYSE:IMPR)
Earnings History by Quarter for Imprivata (NYSE IMPR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/16/2016Q415($0.10)($0.09)$33.15 million$34.20 millionViewListenView Earnings Details
11/2/2015Q315($0.22)($0.27)$31.43 million$29.28 millionViewN/AView Earnings Details
7/29/2015Q215($0.21)($0.15)$29.26 million$30.00 millionViewListenView Earnings Details
5/4/2015Q115($0.31)($0.24)$24.55 million$25.60 millionViewN/AView Earnings Details
11/3/2014Q314($0.16)($0.16)$23.30 million$25.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Imprivata (NYSE:IMPR)
Current Year EPS Consensus Estimate: $-0.49 EPS
Next Year EPS Consensus Estimate: $-0.18 EPS


Dividend History for Imprivata (NYSE:IMPR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Imprivata (NYSE:IMPR)
Insider Ownership Percentage: 40.20%
Institutional Ownership Percentage: 59.34%
Insider Trades by Quarter for Imprivata (NYSE:IMPR)
Institutional Ownership by Quarter for Imprivata (NYSE:IMPR)
Insider Trades by Quarter for Imprivata (NYSE:IMPR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/13/2016David TingCTOSell90,000$18.99$1,709,100.00View SEC Filing  
7/13/2016John A BlaeserDirectorSell7,500$19.01$142,575.00View SEC Filing  
7/12/2016Christopher A ShawSVPSell12,000$14.52$174,240.00View SEC Filing  
7/11/2016Christopher A ShawSVPSell2,300$14.50$33,350.00View SEC Filing  
5/27/2016Entrepreneurs Fund Ii L.P. GcMajor ShareholderSell46,586$13.49$628,445.14View SEC Filing  
5/5/2016Jeffrey KalowskiCFOSell10,000$12.98$129,800.00View SEC Filing  
4/29/2016Omar HussainCEOSell18,936$12.16$230,261.76View SEC Filing  
4/26/2016Omar HussainCEOSell18,564$12.38$229,822.32View SEC Filing  
4/25/2016Omar HussainCEOSell10,922$12.44$135,869.68View SEC Filing  
4/18/2016Thomas W BrigiottaSVPSell10,000$12.81$128,100.00View SEC Filing  
2/16/2016Thomas W. BrigiottaSVPSell10,000$11.24$112,400.00View SEC Filing  
1/15/2016Thomas W. BrigiottaSVPSell10,000$10.64$106,400.00View SEC Filing  
12/23/2015Omar HussainCEOSell30,000$10.70$321,000.00View SEC Filing  
12/1/2015Jeffrey KalowskiCFOSell5,000$11.54$57,700.00View SEC Filing  
11/17/2015Omar HussainCEOSell15,000$10.01$150,150.00View SEC Filing  
11/2/2015Jeffrey KalowskiCFOSell5,000$10.64$53,200.00View SEC Filing  
10/13/2015Jeffrey KalowskiCFOSell1,000$18.01$18,010.00View SEC Filing  
10/12/2015Jeffrey KalowskiCFOSell100$18.00$1,800.00View SEC Filing  
10/2/2015Thomas W. BrigiottaSVPSell5,000$16.68$83,400.00View SEC Filing  
10/1/2015David TingCTOSell8,000$17.32$138,560.00View SEC Filing  
10/1/2015Jeffrey KalowskiCFOSell5,000$17.27$86,350.00View SEC Filing  
9/15/2015Christopher A. ShawSVPSell4,000$19.99$79,960.00View SEC Filing  
9/15/2015Omar HussainCEOSell15,000$19.98$299,700.00View SEC Filing  
9/2/2015Thomas W. BrigiottaSVPSell10,000$19.23$192,300.00View SEC Filing  
9/1/2015Christopher A ShawSVPSell639$20.07$12,824.73View SEC Filing  
9/1/2015David TingCTOSell11,000$20.08$220,880.00View SEC Filing  
9/1/2015Jeffrey KalowskiCFOSell8,639$20.08$173,471.12View SEC Filing  
8/17/2015Omar HussainCEOSell15,000$19.64$294,600.00View SEC Filing  
8/17/2015Thomas W. BrigiottaSVPSell20,000$19.98$399,600.00View SEC Filing  
7/22/2015David TingCTOSell1,229$17.01$20,905.29View SEC Filing  
7/17/2015Christopher A ShawSVPSell2,000$16.01$32,020.00View SEC Filing  
7/15/2015Omar HussainCEOSell10,000$15.78$157,800.00View SEC Filing  
7/2/2015Jeffrey KalowskiCFOSell7,000$15.54$108,780.00View SEC Filing  
7/2/2015Thomas W BrigiottaSVPSell5,000$15.49$77,450.00View SEC Filing  
6/24/2015Christopher A ShawSVPSell2,000$16.10$32,200.00View SEC Filing  
6/18/2015David TingCTOSell3,112$16.30$50,725.60View SEC Filing  
6/16/2015Omar HussainCEOSell10,000$15.00$150,000.00View SEC Filing  
6/2/2015Jeffrey KalowskiCFOSell7,000$15.47$108,290.00View SEC Filing  
6/2/2015Thomas W BrigiottaSVPSell10,000$15.47$154,700.00View SEC Filing  
5/22/2015David TingCTOSell4,383$16.01$70,171.83View SEC Filing  
5/18/2015Omar HussainCEOSell10,000$15.03$150,300.00View SEC Filing  
5/11/2015Christopher A ShawSVPSell2,562$15.05$38,558.10View SEC Filing  
5/8/2015Thomas W BrigiottaSVPSell1,276$15.09$19,254.84View SEC Filing  
5/5/2015Omar HussainCEOSell1,003$15.00$15,045.00View SEC Filing  
5/5/2015Thomas W BrigiottaSVPSell1,155$15.00$17,325.00View SEC Filing  
4/30/2015Christopher A ShawSVPSell1,340$15.01$20,113.40View SEC Filing  
4/30/2015Omar HussainCEOSell2,233$15.01$33,517.33View SEC Filing  
4/23/2015Christopher A ShawSVPSell4,690$15.02$70,443.80View SEC Filing  
4/23/2015David TingCTOSell3,126$15.02$46,952.52View SEC Filing  
4/23/2015Omar HussainCEOSell7,816$15.02$117,396.32View SEC Filing  
4/7/2015Jeffrey KalowskiCFOSell3,701$13.17$48,742.17View SEC Filing  
4/6/2015Jeffrey KalowskiCFOSell6,299$13.76$86,674.24View SEC Filing  
3/31/2015Thomas W BrigiottaSVPSell10,000$13.91$139,100.00View SEC Filing  
6/30/2014David J OrfaoDirectorBuy10,000$13.95$139,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Imprivata (NYSE:IMPR)
Latest Headlines for Imprivata (NYSE:IMPR)
DateHeadline logo'Garden doctor' concept wins Apps for Ag Hackathon - August 1 at 8:33 PM logoTop cybersecurity execs, local investors back Edgewise Networks - July 13 at 3:09 AM logoIGEL Names Brad Tompkins Vice President of Sales for North America - May 2 at 4:20 PM logoImprivata (IMPR) Given Daily News Sentiment Rating of 0.69 - April 23 at 8:00 AM logoImprivata (IMPR) Earns Daily Media Impact Score of 0.37 - April 15 at 11:45 AM logoBaystate Health’s TechSpring Innovation Center Launches Development Environment Based on InterSystems Platform - April 3 at 4:04 PM logoCFO Moves: Anixter International, Rapid7, HSN - November 29 at 4:34 PM logoCFO Moves: Anixter International, Rapid7, HSN - November 29 at 4:34 PM logoHealthcare Biometrics Market Size & Forecast, By Technology, And Trend Analysis To 2024 - September 29 at 5:33 PM logoBRIEF-Unilever says to acquires Seventh Generation Inc - September 19 at 5:40 PM logoDays after buyout closes, Imprivata announces new CEO - September 19 at 5:40 PM logoIMPRIVATA INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - September 14 at 5:44 PM logoThoma Bravo Raises $7.6 Billion for Software, Technology Buyouts - September 12 at 5:29 PM logoNIRI Boston Announces its Board of Directors for the 2016-2017 Programming Year - September 8 at 5:30 PM logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces a Class Action Concerning Whether the Sale of Imprivata, Inc. to Thoma Bravo is Fair to Shareholders – IMPR - August 25 at 5:40 PM logoImprivata Partners with University of Utah Health Care to Implement Positive Patient Identification Across their Healthcare Enterprise - August 15 at 3:16 PM logo9:01 am Imprivata announces that University of Utah Health Care will implement its PatientSecure - August 15 at 3:16 PM



Imprivata (IMPR) Chart for Friday, August, 18, 2017

This page was last updated on 8/18/2017 by Staff